New Key Statistics Module, Z-Score and F-Score
NAS:CLDX Key Ratios
| Market Cap $ M | 2,631.15 |
| Enterprise Value $ M | 1,809.42 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.14 |
| Price/Sales | 332.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -2.86 |
| Beneish M-Score | -1.84 |
| 10-y EBITDA Growth Rate % | 24.40 |
| 5-y EBITDA Growth Rate % | 15.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.05 |
| EV-to-EBITDA | -12.30 |
| PEG | -- |
| Shares Outstanding M | 65.91 |
| Net Margin (%) | -2,385.97 |
| Operating Margin % | -2,473.30 |
| Pre-tax Margin (%) | -2,385.97 |
| Quick Ratio | 31.77 |
| Current Ratio | 31.77 |
| ROA % (ttm) | -32.36 |
| ROE % (ttm) | -34.58 |
| ROIC % (ttm) | -388.92 |
| Dividend Yield % | -- |
| Altman Z-Score | 50.49 |
CLDX Number of Guru Trades
CLDX Volume of Guru Trades
Gurus Latest Trades with NAS:CLDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLDX is held by these investors
Total 2
Celldex Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CLDX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers